News | September 02, 2008

IntraOp to Highlight Single-Dose IOERT Breast Cancer Study

September 3, 2008 - IntraOp will discuss at ASTRO 2008 the recent results of the study which found that a single dose of Intraoperative electron radiotherapy (IOERT) delivered in a single day may be equivalent to six weeks of standard, daily radiation for breast cancer patients.

According to the study, led by by Umberto Veronesi, M.D., director of the European Institute of Oncology in Milan, Italy, a breast surgeon who has pioneered the use of IOERT for this purpose, a single dose of intraoperative electron-beam radiation can be equal to the traditional six-week course for women with breast cancer. The only FDA-approved device available in North America that is capable of delivering the IOERT treatment extolled by Dr. Veronesi in an unshielded operating room is IntraOp’s Mobetron. The Mobetron is a fully portable, self-shielded linear accelerator that can be used in an existing operating room.

Dr. Veronesi presented the results from the first findings of his randomized trial at the recent ISIORT conference in Madrid, Spain, in June 2008. Patients were divided into two groups that received one of two types of treatment: breast conserving surgery and a single dose of IOERT; and breast conserving surgery and traditional six weeks of post-operative radiation therapy. Dr. Veronesi’s study reported that, to date, women who received a single dose of IOERT had identical control, survival and cosmetic results as those who underwent the standard six-week radiation regimen.

From these results, Dr. Veronesi concluded that a single dose of IOERT may be equivalent in outcome to six weeks of post-operative radiation therapy.

For more information: www.intraopmedical.com

Related Content

Gustave Roussy, Elekta, Versa HD, linear accelerators, Mosaiq, France

Image courtesy of Elekta

News | Radiation Therapy | September 04, 2015
Gustave Roussy has awarded Elekta with an order for four Versa HD linear accelerators, replacing their existing...
ECRI Institute, linear accelerators, linac, purchase, survey
News | June 23, 2015
The ECRI Institute released a new techIQ brief on key factors to consider when purchasing a linear accelerator (linac)...
Brainlab, Exactrac, Elekta, Versa HD, LMU Medical Center, Munich
News | June 23, 2015
Brainlab announced first patient treatments in March on a fully integrated radiation oncology solution that combines...
Elekta, William Beaumont Hospital, patent lawsuit, Varian, linear accelerator
News | June 19, 2015
On June 16, 2015, William Beaumont Hospital and Elekta Ltd. filed a patent infringement suit against Varian Medical...
Brainlab, ExacTrac, Versa HD, Elekta, LMU, Munich, LINAC, first
Feature | March 24, 2015
Brainlab announced first patient treatments on a fully integrated radiation oncology solution that combines ExacTrac...
News | September 02, 2014
September 2, 2014 — In an agreement signed in Tokyo, Elekta Japan will grant Toshiba Medical Systems Corp. (TMSC) wider...
News | July 18, 2014
July 18, 2014 — Varian Medical Systems will introduce Qumulate QA, a new cloud-based QA data management and analysis...
News | June 11, 2014
June 11, 2014 — Erasmus University Medical Center (Erasmus MC) in Rotterdam, the Netherlands, announced the purchase of...
Elekta Learning and Innovation Center Atlanta ASTRO 2013 Oncology Neuroscience
News | October 02, 2013
Elekta unveiled a state-of-the-art learning center at its North American headquarters, in conjunction with the 55th...
News | September 24, 2013
Varian Medical Systems and Siemens Healthcare showcased a variety of solutions that bring together Siemens' world-class...
Overlay Init